Comparison between Equitas Holdings IPO and Thyrocare Technologies IPO.
Equitas Holdings IPO is a Mainboard Bookbuilding IPO proposed to list at BSE, NSE while Thyrocare Technologies IPO is a Mainboard Bookbuilding proposed to list at BSE, NSE.
The total issue size of Equitas Holdings IPO is up to ₹2,176.68 Cr whereas the issue size of the Thyrocare Technologies IPO is up to ₹479.21 Cr. The final issue price of Equitas Holdings IPO is ₹110.00 per share and of Thyrocare Technologies IPO is ₹446.00 per share.
| Equitas Holdings IPO | Thyrocare Technologies IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ₹109.00 per share | ₹420.00 per share |
| Issue Price (Upper) | ₹110.00 per share | ₹446.00 per share |
| Issue Price (Final) | ₹110.00 per share | ₹446.00 per share |
| Discount (Retail) | ₹0.00 per share | ₹0.00 per share |
| Discount (Employee) | ₹0.00 per share | |
| Market Lot Size | 135 shares | 33 shares |
| Fresh Issue Size | 6,54,54,545 shares | 0 shares |
| Fresh Issue Size (Amount) | up to ₹720.00 Cr | up to ₹0.00 Cr |
| OFS Issue Size | 13,24,25,884 shares | 1,07,44,708 shares |
| OFS Issue Size (Amount) | up to ₹1,456.68 Cr | up to ₹479.21 Cr |
| Issue Size Total | 19,78,80,429 shares | 1,07,44,708 shares |
| Issue Size Total (Amount) | up to ₹2,176.68 Cr | up to ₹479.21 Cr |
Equitas Holdings IPO opens on Apr 05, 2016, while Thyrocare Technologies IPO opens on Apr 27, 2016. The closing date of Equitas Holdings IPO and Thyrocare Technologies IPO is Apr 07, 2016, and Apr 29, 2016, respectively.
| Equitas Holdings IPO | Thyrocare Technologies IPO | |
|---|---|---|
| Anchor Bid Date | Apr 04, 2016 | Apr 26, 2016 |
| Issue Open | Apr 05, 2016 | Apr 27, 2016 |
| Issue Close | Apr 07, 2016 | Apr 29, 2016 |
| Basis Of Allotment (Tentative) | ||
| Initiation of Refunds (Tentative) | ||
| Credit of Share (Tentative) | ||
| Listing date (Tentative) | Apr 21, 2016 | May 09, 2016 |
| Anchor Lockin End date 1 | ||
| Anchor Lockin End date 2 |
Equitas Holdings IPO P/E ratio is , as compared to Thyrocare Technologies IPO P/E ratio of .
| Equitas Holdings IPO | Thyrocare Technologies IPO | |||||
|---|---|---|---|---|---|---|
| Financials | Company Financials ()
| Company Financials ()
| ||||
| Promoter Shareholding (Pre-Issue) | 64.96 | |||||
| Promoter Shareholding (Post-Issue) | 63.96 | |||||
| P/E Ratio | ||||||
| Market Cap | ₹4166.03 Cr. | ₹2396.07 Cr. | ||||
| ROE | ||||||
| ROCE | ||||||
| Debt/Equity | ||||||
| EPS | ||||||
| RoNW | 17.37% |
In the Equitas Holdings IPO Retail Individual Investors (RII) are offered 6,91,70,651 shares while in Thyrocare Technologies IPO retail investors are offered 6,91,70,651 shares. Qualified Institutional Buyers (QIB) are offered 3,95,26,086 shares in Equitas Holdings IPO and 21,48,942 shares in Thyrocare Technologies IPO.
| Equitas Holdings IPO | Thyrocare Technologies IPO | |
|---|---|---|
| Anchor Investor Reservation | 5,92,89,127 shares | 32,23,411 shares |
| Market Maker Reservation | ||
| QIB | 3,95,26,086 shares | 21,48,942 shares |
| NII | 2,96,44,565 shares | 16,11,707 shares |
| RII | 6,91,70,651 shares | 37,60,648 shares |
| Employee | 2,50,000 shares | |
| Others | ||
| Total | 19,78,80,429 shares | 1,07,44,708 shares |
Equitas Holdings IPO subscribed 17.21x in total, whereas Thyrocare Technologies IPO subscribed 73.55x.
| Equitas Holdings IPO | Thyrocare Technologies IPO | |
|---|---|---|
| QIB (times) | 14.93x | 73.18x |
| NII (times) | 57.29x | 225.30x |
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | 1.40x | 8.73x |
| Employee (times) | 0.89x | |
| Other (times) | ||
| Total (times) | 17.21x | 73.55x |
